Exclusive news, analysis, and commentary on large or significant mergers, deal breakups, and the key players making the decisions.
Occidental Petroleum, the oil giant in Berkshire Hathaway’s portfolio, announced it is acquiring CrownRock in a deal worth $12 billion.
Following merger discussions two weeks ago, Humana and Cigna are walking away from what would’ve been the largest deal of the year.
Exxon’s $60 billion planned acquisition of Pioneer Natural Resources has attracted the attention of the Federal Trade Commission.
Roche agreed Monday to acquire anti-obesity drug developer Carmot Therapeutics for an appetizing $3.1 billion.
In a bid to scale up against larger rivals, health insurance players Cigna and Humana are reportedly in talks over a possible merger.
On Monday, Chevron said it would acquire energy player Hess for $53 billion. It’s the latest megadeal in a wildly active industry this month.
Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.